THE MEDICAL UNIVERSITY OF SOUTH CAROLINA Hollings Cancer Center's Mount Pleasant location installed TrueBeam imaging capabilities for patients, as well as several types of external beam radiation therapy.
JOHNATHAN LANCASTER joined Myriad Genetics as vice president of medical affairs for oncology in Myriad Genetic Laboratories, effective Feb. 9.
WUXI PHARMATECH (Cayman) Inc. acquired NextCODE Health for $65 million in cash, with plans to merge NextCODE and WuXi's Genome Center into a new company, named WuXi NextCODE Genomics.
CITY OF HOPE and Trovagene Inc. entered into a clinical collaboration to conduct studies on detecting and monitoring EGFR mutations in lung cancer patients using Trovagene's Precision Cancer Monitoring platform.
CARIS LIFE SCIENCES established the Caris Centers of Excellence for Precision Medicine Network, appointing John Marshall as chairman.
THE PANCREATIC CANCER ACTION NETWORK and NCI's Frederick National Laboratory for Cancer Research will award two fellowships to support research on KRAS mutations that are relevant to pancreatic cancer.
SUE BIGGINS was awarded the Edward Novitski Prize by the Genetics Society of America.
A new study indicates that the risk of developing cancer in some types of tissue is based on the frequency of stem cell divisions, and therefore beyond individuals' control to minimize their own risks. As the study stated, a majority of these cancers develop due to random mutations of noncancerous stem cells; in other words, it's just “bad luck.”
The American Society of Clinical Oncologyannounced Jan. 21 that its CancerLinQ health information technology project will use the SAP HANA platform.
President Barack Obama called for innovation in genetic medicine, through the launch of a new initiative, in his State of the Union address Jan. 20.
